Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Argus Health
Express Scripts
Moodys
Farmers Insurance
Fuji
Healthtrust
Fish and Richardson
Cantor Fitzgerald

Generated: October 15, 2018

DrugPatentWatch Database Preview

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - Generic Drug Details

« Back to Dashboard

What are the generic sources for amlodipine besylate; olmesartan medoxomil and what is the scope of amlodipine besylate; olmesartan medoxomil patent protection?

Amlodipine besylate; olmesartan medoxomil is the generic ingredient in two branded drugs marketed by Accord Hlthcare Inc, Ajanta Pharma Ltd, Alembic Pharms Ltd, Alkem Labs Ltd, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Micro Labs, Teva Pharms Usa, Torrent Pharms Ltd, Zydus Pharms Usa Inc, and Daiichi Sankyo, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for amlodipine besylate; olmesartan medoxomil. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Tentative approvals for AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up10MG/40MGTABLET; ORAL
➤ Sign Up➤ Sign Up10MG/20MGTABLET; ORAL
➤ Sign Up➤ Sign Up5MG/40MGTABLET; ORAL

US Patents and Regulatory Information for AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207450-003 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare Inc AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209600-002 Aug 30, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Torrent Pharms Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 202933-001 Nov 25, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209042-002 Aug 14, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-001 Sep 26, 2007 ➤ Sign Up ➤ Sign Up
Daiichi Sankyo AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-003 Sep 26, 2007 ➤ Sign Up ➤ Sign Up
Daiichi Sankyo AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-004 Sep 26, 2007 ➤ Sign Up ➤ Sign Up
Daiichi Sankyo AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-002 Sep 26, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Argus Health
Express Scripts
Moodys
Farmers Insurance
Fuji
Healthtrust
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.